A-582941

• CAT Number: I000286
• CAS Number: 848591-89-9
• Molecular Formula: C17H20N4
• Molecular Weight: 280.375
• Purity: ≥95%
• Target: alpha7 nicotinic acetylcholine receptor agonist
• Solubility: Soluble in DMSO
• Storage: Store at RT
• IUPAC Name: 2-methyl-5-(6-phenylpyridazin-3-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole
• InChI: InChI=1S/C17H20N4/c1-20-9-14-11-21(12-15(14)10-20)17-8-7-16(18-19-17)13-5-3-2-4-6-13/h2-8,14-15H,9-12H2,1H3
• InChIKey: GTMRUYCIJSNXGB-UHFFFAOYSA-N
• SMILES: CN1CC2CN(CC2C1)C3=NN=C(C=C3)C4=CC=CC=C4

A-582941 (CAT: I000286) is a novel agonist of the alpha7 subtype of nicotinic acetylcholine receptors (nAChRs). By binding and activating the alpha7 nAChR, A-582941 modulates downstream signaling pathways associated with neurotransmission, cognitive function, and inflammation. Its selective agonistic activity at the alpha7 nAChR makes A-582941 a promising compound for potential therapeutic applications in neurological disorders such as Alzheimer’s disease, schizophrenia, and cognitive impairments. Further exploration of A-582941’s effects on alpha7 nAChR activation may provide valuable insights into the development of treatments targeting this receptor subtype.

Reference

1: Toyohara J, Ishiwata K, Sakata M, Wu J, Nishiyama S, Tsukada H, Hashimoto K.
In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists
[11C]A-582941 and [11C]A-844606 in mice and conscious monkeys. PLoS One. 2010 Feb
1;5(2):e8961. doi: 10.1371/journal.pone.0008961. PubMed PMID: 20126539; PubMed
Central PMCID: PMC2813863.
2: Thomsen MS, Mikkelsen JD, Timmermann DB, Peters D, Hay-Schmidt A, Martens H,
Hansen HH. The selective alpha7 nicotinic acetylcholine receptor agonist A-582941
activates immediate early genes in limbic regions of the forebrain: Differential
effects in the juvenile and adult rat. Neuroscience. 2008 Jun 23;154(2):741-53.
doi: 10.1016/j.neuroscience.2008.03.083. Epub 2008 Apr 16. PubMed PMID: 18495359.
3: Tietje KR, Anderson DJ, Bitner RS, Blomme EA, Brackemeyer PJ, Briggs CA,
Browman KE, Bury D, Curzon P, Drescher KU, Frost JM, Fryer RM, Fox GB, Gronlien
JH, Håkerud M, Gubbins EJ, Halm S, Harris R, Helfrich RJ, Kohlhaas KL, Law D,
Malysz J, Marsh KC, Martin RL, Meyer MD, Molesky AL, Nikkel AL, Otte S, Pan L,
Puttfarcken PS, Radek RJ, Robb HM, Spies E, Thorin-Hagene K, Waring JF, Ween H,
Xu H, Gopalakrishnan M, Bunnelle WH. Preclinical characterization of A-582941: a
novel alpha7 neuronal nicotinic receptor agonist with broad spectrum
cognition-enhancing properties. CNS Neurosci Ther. 2008 Spring;14(1):65-82. doi:
10.1111/j.1527-3458.2008.00037.x. Review. PubMed PMID: 18482100.
4: Buccafusco JJ, Terry AV Jr, Decker MW, Gopalakrishnan M. Profile of nicotinic
acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype
selectivity, on delayed matching accuracy by young monkeys. Biochem Pharmacol.
2007 Oct 15;74(8):1202-11. Epub 2007 Jul 14. PubMed PMID: 17706609.